Testing continuous glucose sensors in newborns
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study checks how well continuous glucose monitors work in newborns. It aims to improve care for babies by making glucose monitoring easier and less invasive.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You speak English, Spanish, Portuguese, or Haitian Creole
- You are more than 24 weeks pregnant with one baby
- You plan to deliver at Women and Infants Hospital of Rhode Island
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a continuous glucose monitor can safely track blood sugar levels in newborns. It may help doctors better understand glucose patterns in babies at birth.
This trial uses a continuous glucose monitor (a small sensor placed on the skin) to track blood sugar levels in newborns whose mothers used insulin for gestational diabetes. The goal is to see if this monitoring helps prevent low blood sugar in babies.
This study tests a continuous glucose monitor (a small patch that tracks your blood sugar) for a few weeks after you give birth. It aims to see if this tool can help women who recently had gestational diabetes better understand their blood sugar levels after delivery.
This study tests whether using a continuous glucose monitor (a small sensor that tracks your blood sugar) along with support from others can help prevent or manage high blood sugar during pregnancy. It is for pregnant women under 20 weeks who have certain risk factors for gestational diabetes.
This study tests whether a continuous glucose monitor (a small sensor that checks your blood sugar levels all day) can help women with gestational diabetes manage their blood sugar more easily. The goal is to see if it improves health for both mom and baby.
This study uses a continuous glucose monitor to check blood sugar levels after giving birth in people who had gestational diabetes. It aims to find early signs of abnormal blood sugar and may help you understand your risk for type 2 diabetes.
Hear when a new Neonatal Hypoglycemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.